» Authors » Xiao-Xiong Wu

Xiao-Xiong Wu

Explore the profile of Xiao-Xiong Wu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 118
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gu Z, Dong Y, Fu X, Li N, Liu Y, Wu X, et al.
Chin Med J (Engl) . 2021 Jun; 134(13):1584-1592. PMID: 34133361
Background: There were few studies on real-world data about autologous hematopoietic stem cell transplantation (auto-HSCT) or allogeneic HSCT (allo-HSCT) in peripheral T-cell lymphoma (PTCL). This study aimed to investigate the...
2.
Cheng L, Guan W, Duan C, Zhang N, Lei C, Hu Y, et al.
JAMA Intern Med . 2020 Sep; 181(1):71-78. PMID: 32910179
Importance: Lymphopenia is common and correlates with poor clinical outcomes in patients with coronavirus disease 2019 (COVID-19). Objective: To determine whether a therapy that increases peripheral blood leukocyte and lymphocyte...
3.
Liu S, Wu X, Hua T, Xin X, Feng D, Chi S, et al.
Onco Targets Ther . 2019 Nov; 12:6927-6936. PMID: 31695408
Background: Activation of NLPR3 inflammasome is associated with the development and progression of some types of malignant tumors, but its role in endometrial cancer is unclear. This study aimed to...
4.
Wang B, Wu Y, Li X, Xu L, Wang J, Yan B, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2018 Dec; 26(6):1731-1737. PMID: 30501712
Objective: To explore the relationship between HLA-A, -B, -C, -DRB1, -DQB1 gene polymorphism and aplastic anemia (AA)of 65 cases in Northern China. Methods: The high resolution genotyping of HLA-A, -B,...
5.
Wu Y, Cao Y, Li X, Xu L, Yan B, Li S, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2017 Jun; 25(3):885-889. PMID: 28641654
Objective: To investigate the efficacy and clinical safety of posaconazoleon primary antifungal prophylaxis against invasive fungal disease (IFD) in patients with stem cell transplantation. Methods: At the start from preconditioning...
6.
Wang L, Yan B, Yu Y, Wang Y, Yang H, Zhao H, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2017 Mar; 25(1):126-132. PMID: 28245388
Background: A survey of early stage follicular lymphoma(FL) revealed that the rigorously staged FL patients at first diagnosis had a better outcome as compared with non-rigorous staged FL patients, but...
7.
Wang L, Wu Y, Cao Y, Li X, Xu L, Wang H, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2016 Dec; 24(6):1817-1823. PMID: 28024500
Objective: To analyse the feasibility and compare differences between hematopoietic reconstitution and prognosis of patients with severe aplastic anemia(SAA) after matched sibling donor (MSD) or haploidentical family donor (HFD) hematopoietic...
8.
Yang X, Wu Y, Cao Y, Li X, Xu L, Liu Z, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2016 Dec; 24(6):1743-1747. PMID: 28024487
Objective: To investigate the safety and effectiveness of autologous hematopoietic stem cell transplantation (auto-HSCT) using tumor-ablative conditioning regiment for patients with refractory/relapsed non-Hodgkin's lymphoma. Methods: The clinical data of 16...
9.
Wang H, Yang B, Hu B, Chi X, Luo L, Yang H, et al.
Cancer Med . 2016 May; 5(8):2012-21. PMID: 27228575
Amifostine is a cytoprotective drug that was initially used to control and treat nuclear radiation injury and is currently used to provide organ protection in cancer patients receiving chemotherapy. Clinical...
10.
Yang X, Wu Y, Cao Y, Li X, Xu L, Liu Z, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2015 Aug; 23(4):1056-61. PMID: 26314446
Objective: To investigate the therapeutic efficacy and side effects of treating patients with myelodysplastic syndrome-RAEB (MDS-RAEB) and with refractory acute myeloid leukemia (AML) by using decitabine combined with CAG regimen....